Clinical effects of cyclophosphamide in Guillain-Barré polyneuritis
- 1 November 1976
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 30 (1) , 179-187
- https://doi.org/10.1016/0022-510x(76)90265-3
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Non-Randomized Controls in Cancer Clinical TrialsNew England Journal of Medicine, 1974
- Epidemiologic features of the Guillain‐Barré syndromeNeurology, 1973
- Diagnostic criteria for the Guillain-Barré syndrome: An analysis of 50 casesJournal of the Neurological Sciences, 1971
- Immunosuppression and the Guillain-Barre SyndromeArchives of Neurology, 1970
- POLYRADICULONEUROPATHY TREATED WITH CYTOTOXIC DRUGSThe Lancet, 1966
- MERCAPTOPURINE IN POLYRADICULONEUROPATHYThe Lancet, 1966
- 6-MERCAPTOPURINE IN POLYRADICULONEUROPATHYThe Lancet, 1965
- POLYRADICULONEUROPATHY (GUILLAIN-BARRÉSYNDROME) TREATED WITH 6-MERCAPTOPURINEThe Lancet, 1965
- SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY ANTIMETABOLITESAnnals of the New York Academy of Sciences, 1965
- Recognition, Prognosis and Treatment of the Guillain-Barré Syndrome (Acute Idiopathic Polyneuritis)Medical Clinics of North America, 1963